These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1180 related articles for article (PubMed ID: 17684158)
1. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
2. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
4. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
5. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells. Su L; Liu G; Hao X; Zhong N; Zhong D; Liu X; Singhal S Eur J Cancer; 2011 Nov; 47(16):2471-8. PubMed ID: 21726997 [TBL] [Abstract][Full Text] [Related]
6. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935 [TBL] [Abstract][Full Text] [Related]
7. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244 [TBL] [Abstract][Full Text] [Related]
8. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP. He Q; Luo X; Jin W; Huang Y; Reddy MV; Reddy EP; Sheikh MS Oncogene; 2008 Apr; 27(18):2656-60. PubMed ID: 17968315 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
10. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells. Palacios C; Yerbes R; López-Rivas A Cancer Res; 2006 Sep; 66(17):8858-69. PubMed ID: 16951203 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587 [TBL] [Abstract][Full Text] [Related]
12. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887 [TBL] [Abstract][Full Text] [Related]
13. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136 [TBL] [Abstract][Full Text] [Related]
14. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737 [TBL] [Abstract][Full Text] [Related]
15. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731 [TBL] [Abstract][Full Text] [Related]
16. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
17. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Cancer Res; 2006 Dec; 66(23):11115-9. PubMed ID: 17145853 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
19. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639 [TBL] [Abstract][Full Text] [Related]
20. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]